8th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC)

The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view.

The major topics of the conference are:
• Epidemiology
• Thromboprophylaxis in Medical Patients
• Treatment of VTE
• Thromboprophylaxis in Surgical Patients
• Hypercoagulation and Biomarkers
• Complement-driven Thrombotic Syndromes
• Gender- and Age-related Issues
• Hemostasis in Cancer Biology
• Molecular Mechanisms of Thrombosis in Cancer
• Tumor Cell/Vascular Cell Interactions
• Angiogenesis
• Inflammation
• New Antithrombotic Drugs
• Anticoagulation and Cancer Survival
• Arterial Thrombosis
• Bleeding
• Congenital and Acquired Risk Factors
• Thrombohemorrhagic Syndromes (e.g. DIC, TTP, NBTE, VOD)
• Antitumor Properties of Antithrombotics
• Microparticles
• New Assays for Hypercoagulability
• Fibrinolysis
• Proteases

The registrations fees are:

Early Registration (i.e. until January 31st, 2016): Euro 500,00 (VAT included)
Full Registration (regular, after January 31st, 2016): Euro 650,00 (VAT included)
Abstract presenting author: Euro 500,00 (VAT included)
ISTH Member: Euro 500,00 (VAT included)
Student Registration: Euro 150,00 (VAT included)
On-site registration : Euro 750,00 (VAT included)